What you need to know about your COVID-19 vaccine card, and what to do if you lose it
Here are some answers to common questions about COVID-19 vaccine cards, including what happens if it is lost or damaged.
Here are some answers to common questions about COVID-19 vaccine cards, including what happens if it is lost or damaged.
US opens more distance in worldwide race against COVID-19 as it nears 200M vaccines administered
Nearly half of American adults have gotten at least one dose of the vaccine, and about 30% have been fully vaccinated. But the picture is still relentlessly grim in parts of Europe, Latin America, Africa and Asia.
Nearly half of American adults have gotten at least one dose of the vaccine, and about 30% have been fully vaccinated. But the picture is still relentlessly grim in parts of Europe, Latin America, Africa and Asia.
Brooklyn Nets' LaMarcus Aldridge retires at 35 due to heart condition
LaMarcus Aldridge retired from the NBA on Thursday after saying he experienced an irregular heartbeat during his final game with the Brooklyn Nets.
LaMarcus Aldridge retired from the NBA on Thursday after saying he experienced an irregular heartbeat during his final game with the Brooklyn Nets.
Unemployment claims fall to 576,000, lowest since COVID-19 pandemic began
The number of Americans applying for unemployment benefits fell sharply last week to 576,000, a hopeful sign that layoffs are easing as the economy recovers from the pandemic recession.
The number of Americans applying for unemployment benefits fell sharply last week to 576,000, a hopeful sign that layoffs are easing as the economy recovers from the pandemic recession.
Most kids with MIS-C had mild COVID-19, some also developed neurological symptoms, research shows
New research has found that most kids with a serious inflammatory illness linked to the coronavirus had no COVID-19 symptoms or just mild ones. Another small study found that many MIS-C patients also suffered neurological symptoms.
New research has found that most kids with a serious inflammatory illness linked to the coronavirus had no COVID-19 symptoms or just mild ones. Another small study found that many MIS-C patients also suffered neurological symptoms.
NY Philharmonic hosts first performance in 13 months to small crowd at The Shed
The New York Philharmonic had not gathered before an audience for exactly 400 days when it finally held a performance Wednesday night.
The New York Philharmonic had not gathered before an audience for exactly 400 days when it finally held a performance Wednesday night.
Recovering social skills as COVID pandemic winds down
After living under COVID restrictions for over a year, you're not alone if you're finding interacting with people again a little awkward.
After living under COVID restrictions for over a year, you're not alone if you're finding interacting with people again a little awkward.
Granddaughters of women exposed to DDT have 2-3 times higher chance of obesity, early periods, study says
A recent study found that granddaughters of women who were exposed to the now-banned chemical pesticide, DDT, have 2-3 times higher chances of experiencing obesity and earlier periods.
A recent study found that granddaughters of women who were exposed to the now-banned chemical pesticide, DDT, have 2-3 times higher chances of experiencing obesity and earlier periods.
Pollen could play role increased COVID-19 infection rates, study suggests
The spring season correlates with increased pollen counts, and according to a new study, the common allergen could be making COVID-19 infection rates worse.
The spring season correlates with increased pollen counts, and according to a new study, the common allergen could be making COVID-19 infection rates worse.
Potential HIV vaccine utilizing same mRNA technology as COVID-19 vaccine shows promise in early human trial
A potential HIV vaccine that utilizes he same mRNA technology as the COVID-19 vaccine from Moderna is showing promising results.
A potential HIV vaccine that utilizes he same mRNA technology as the COVID-19 vaccine from Moderna is showing promising results.
J&J COVID-19 vaccine pause to remain in place while officials seek more evidence on rare clots
The pause on Johnson & Johnson’s COVID-19 vaccine will remain in place for now after U.S. health advisers said they need more evidence to make any decision about the rare blood clots reported.
The pause on Johnson & Johnson’s COVID-19 vaccine will remain in place for now after U.S. health advisers said they need more evidence to make any decision about the rare blood clots reported.
2 new studies find UK B.1.1.7 coronavirus variant more transmissible, but not linked to COVID-19 severity
Two new studies analyzing the worrisome B.1.1.7 coronavirus variant that first emerged in the U.K. found that while the strain is more transmissible, it did not appear to cause more severe COVID-19 illness.
Two new studies analyzing the worrisome B.1.1.7 coronavirus variant that first emerged in the U.K. found that while the strain is more transmissible, it did not appear to cause more severe COVID-19 illness.
Researchers launch study on whether Apple Watch, iPhones can detect illnesses like COVID-19
A study to test out if Apple Watches and iPhones can detect certain illnesses, such as COVID-19, is accepting participants in the Seattle area.
A study to test out if Apple Watches and iPhones can detect certain illnesses, such as COVID-19, is accepting participants in the Seattle area.
'Zoom in a Room:' California ranks last in the country for reopening schools
California, the most populated state is lagging the rest of the country in reopening schools — and in some cases offering options that parents say are unacceptable.
California, the most populated state is lagging the rest of the country in reopening schools — and in some cases offering options that parents say are unacceptable.
Moderna CEO says company anticipates ‘a lot of variants’ of coronavirus in next year
Moderna CEO Stéphane Bancel said he anticipates the world will see many coronavirus variants over “the next year or so” and hopes to have a booster shot by the fall.
Moderna CEO Stéphane Bancel said he anticipates the world will see many coronavirus variants over “the next year or so” and hopes to have a booster shot by the fall.
NFL says more than 2M COVID-19 vaccines administered at its stadiums
The NFL announced Wednesday that more than 2 million COVID-19 vaccinations have been administered at its stadiums and facilities since starting the campaign earlier this year.
The NFL announced Wednesday that more than 2 million COVID-19 vaccinations have been administered at its stadiums and facilities since starting the campaign earlier this year.
7-day average of daily COVID-19 cases in US above 70,000 as states reopen, life resumes amid ongoing pandemic
As states continue to reopen, daily coronavirus cases in the United States are beginning to rise again, triggering worry among experts of a new COVID-19 surge.
As states continue to reopen, daily coronavirus cases in the United States are beginning to rise again, triggering worry among experts of a new COVID-19 surge.
6-year-old gets hero's welcome back to school after completing cancer treatment
Nathan Herber, 6, got a hero's welcome from his fellow classmates after completing his cancer treatments.
Nathan Herber, 6, got a hero's welcome from his fellow classmates after completing his cancer treatments.
Masks could be delaying development among babies
Babies could be behind on speech and emotional recognition due to everyone wearing masks during the pandemic.
Babies could be behind on speech and emotional recognition due to everyone wearing masks during the pandemic.
NFL to restrict access of team employees who refuse COVID-19 vaccine without ‘bona fide’ reason
The NFL is requiring certain team employees to have a “bona fide” reason to forego the COVID-19 vaccine or get barred from restricted areas.
The NFL is requiring certain team employees to have a “bona fide” reason to forego the COVID-19 vaccine or get barred from restricted areas.